Displaying 841 - 860 of 1020 results

Division of Extramural Research

https://www.niams.nih.gov/es/node/11181

The Division of Extramural Research (DER) provides scientific management of the largest federal investment on arthritis, musculoskeletal, and skin diseases research conducted in academic institutions across the country. The DER consists of several distinct scientific and special programs, each headed by a program director. DER works with leadership at NIAMS

Frequently Asked Questions for PAR-24-289 (R01) and PAR-25-230 (R21): Ancillary Studies to Ongoing Clinical Projects (Clinical Trial Not Allowed)

https://www.niams.nih.gov/es/node/10221

Applicants with additional questions are highly encouraged to contact their Program Director . These FAQs apply to the following funding opportunities: Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) (PAR-24-289) Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) (PAR-25-230)

Elif Eren, Ph.D.

https://www.niams.nih.gov/es/node/10311

Dr. Eren is a structural biochemist studying viral protein interactions with host proteins, nucleic acids, and antibodies using x-ray crystallography and cryo-EM. Her research focuses on novel drug targets and therapeutics for HIV-1, HBV, and SARS-CoV-2.

New NIH Research Grants Honor Legacy of Former NIAMS Director Stephen I. Katz, M.D., Ph.D.

https://www.niams.nih.gov/es/node/10326

We at NIAMS are excited as we look forward to the arrival of Lindsey Criswell as the new Director but our thoughts also turn back to memories of our previous Director, Steve Katz. He was a unique voice who guided the NIAMS as director for more than two decades and who spent his career mentoring the next generations of researchers. With this in mind, I am pleased to share news of new awards that give the NIH a unique way to encourage the scientists of tomorrow.

Data and Safety Monitoring (DSM) Guidelines for Internal Safety Monitoring

https://www.niams.nih.gov/es/node/10731

Learn NIAMS guidance and guidelines for studies that use internally-appointed monitoring for the oversight of NIAMS-funded clinical research. TABLE OF CONTENTS 1.0 Internally-appointed Monitoring 1.1 Roles and Responsibilities of the PI 1.2 Responsibilities of Internally-appointed Monitoring Body 1.2.a Internal Safety Monitoring Process 1.2.b Internal Review of Data and Safety Reports

Typically materials from NIAMS that are more than 5 years old will be archived.